Revised for 2nd substitute: Concerning the 340B drug pricing program.

This bill aims to protect patient access to discounted medications by preventing drug manufacturers from restricting the 340B drug pricing program. It affects healthcare providers that serve low-income and uninsured populations, as well as drug manufacturers and distributors. If passed, the bill would prohibit manufacturers from limiting how these providers access discounted drugs through contract pharmacies and would establish penalties for violations, while also requiring covered entities to report data on their 340B program participation.

No official summary on file for this bill · generated by Gemini 2.5 Flash from its full text